Next Article in Journal
Trends in Efficacy Endpoints in Phase II Glioblastoma Trials: A Regulatory Science Analysis (FY2020–FY2022)
Previous Article in Journal
Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression
Previous Article in Special Issue
Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders
 
 
cancers-logo
Article Menu

Article Menu

Article

Article Versions Notes

Cancers 2025, 17(5), 854; https://doi.org/10.3390/cancers17050854
Action Date Notes Link
article xml file uploaded 1 March 2025 10:47 CET Original file -
article xml uploaded. 1 March 2025 10:47 CET Update https://www.mdpi.com/2072-6694/17/5/854/xml
article pdf uploaded. 1 March 2025 10:47 CET Version of Record https://www.mdpi.com/2072-6694/17/5/854/pdf
article supplementary file uploaded. 1 March 2025 10:47 CET - https://www.mdpi.com/2072-6694/17/5/854#supplementary
article html file updated 1 March 2025 10:48 CET Original file -
article html file updated 24 June 2025 18:38 CEST Update https://www.mdpi.com/2072-6694/17/5/854/html
Back to TopTop